BioSpace News Archive

Positive outcome and two-year contract are the result of first negotiations between Brigham and MNA nurses since historic near strike in 2016

Clinically superior next generation device reduces hair loss for cancer patients

Emergex Vaccines Holding Limited announced that it has signed an R&D agreement with the Institute of Molecular and Cell Biology (IMCB) in Singapore to develop a fully synthetic vaccine against human viruses that cause Hand, Foot and Mouth Disease (HFMD).

MODAG announced the completion of a EUR 12 million Series A financing round, launching out of stealth mode to advance lead candidate anle138b into clinical development in Multiple System Atrophy (MSA).

The Leapfrog Group released its 2019 Never Events Report, and found that one in four participating hospitals do not meet The Leapfrog Group’s standard for handling of serious reportable events that should never happen to a patient, known as “Never Events.” The report is based on the findings from the 2018 Leapfrog Hospital Survey, with data voluntarily submitted by more than 2,000 U.S. hospitals.

Event will provide an R&D and portfolio review across the depression, neurology and neuropsychiatric franchises

Acreage Holdings, Inc. and Canopy Growth Corporation are pleased to announce the implementation of Acreage’s previously announced arrangement under section 288 of the Business Corporations Act with Canopy Growth.

Company Experiencing Significant Growth in the Southeast

Benvenue Medical, Inc., an innovative developer of minimally invasive surgery expandable implant solutions for lumbar fusions, announced that it has received U.S. Food and Drug Administration 510 clearance for the company’s enhanced Luna® XD MIS expandable interbody device.

Takeda Pharmaceutical Company Limited hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2019 with the U.S. Securities and Exchange Commission.